Compare ITP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITP | BRTX |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | China | United States |
| Employees | N/A | 14 |
| Industry | Paper | Managed Health Care |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 3.7M |
| IPO Year | 2020 | 2015 |
| Metric | ITP | BRTX |
|---|---|---|
| Price | $0.17 | $2.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 303.3K | 202.6K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,837,943.00 | $81,000.00 |
| Revenue This Year | N/A | $298.39 |
| Revenue Next Year | N/A | $64.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.15 | $0.14 |
| 52 Week High | $0.39 | $4.10 |
| Indicator | ITP | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 62.80 |
| Support Level | $0.16 | $0.22 |
| Resistance Level | $0.20 | $4.10 |
| Average True Range (ATR) | 0.01 | 0.41 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 34.01 | 65.76 |
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.